- American City Business Journals•3 days ago
Dan Santi could have taken his biotech startup, which has an innovative technology for keeping drugs in the body longer, anywhere in the Bay Area. Over the past five years in the CoLaborator incubator inside Bayer AG's Mission Bay outpost, Santi’s ProLynx LLC struck collaborations with Bayer and other drug companies that set the stage for taking its first drug into human clinical trials.
- The Wall Street Journal•4 days ago
Fusion Pharmaceuticals Inc. has raised $25 million in a bid to build on the success of a new radio-pharmaceutical from Bayer AG that extends life for certain prostate cancer patients.
- Zacks•4 days ago
Bayer AG's (BAYRY) fourth-quarter 2016 core earnings increased 10.2% year over year to ???1.19 per share (approximately $1.28). Reported earnings missed the Zacks Consensus Estimate of $1.37.
BAYN.DE : Summary for BAYER AG NA O.N. - Yahoo Finance
Bayer Aktiengesellschaft (BAYN.DE)
XETRA - XETRA Delayed Price. Currency in EUR
Add to watchlist
|Bid||104.50 x 28400|
|Ask||104.55 x 2100|
|Day's Range||104.25 - 105.10|
|52 Week Range||83.45 - 112.00|
|PE Ratio (TTM)||18.43|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|